ArticleFrontiers in neurology
Premenstrual syndrome, premenstrual dysphoric disorder, and coping strategies in women with menstrual migraine.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objectives: Despite the considerable prevalence of premenstrual syndrome (PMS) in women with migraine, little attention has been given to the applied premenstrual coping strategies and their impact on headache severity, especially in menstrual migraine (MM). Therefore, this study aimed to investigate the severity of PMS, the Premenstrual Dysphoric Disorder (PMDD), the coping strategies used among women with MM versus those with non-MM, and to determine their impact on their perceived headache burden. Methods: In this cross-sectional study, existing diary data covering at least three consecutive menstrual cycles were reviewed to classify participants as having MM or non-MM. All patients were evaluated by the Headache Impact Test-6 (HIT-6), Premenstrual Symptoms Screening Tool (PSST) and the Premenstrual Coping Measure. Results: This study was conducted on 445 females with MM and 156 with non-MM. Females with MM had significantly higher PSST and HIT-6 scores ( Conclusion: Women with a confirmed diagnosis of PMDD, high PMS symptom severity and lower frequency of using the awareness and acceptance coping strategy are at risk of increased headache burden.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.